GSA Capital Partners’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$307K Buy
+1,798
New +$228K 0.02% 1290
2025
Q4
Sell
-4,729
Closed -$489K 1957
2025
Q3
$489K Buy
4,729
+1,110
+31% +$109K 0.04% 863
2025
Q2
$451K Buy
+3,619
New +$467K 0.03% 997
2024
Q1
Sell
-3,382
Closed -$91K 1860
2023
Q4
$91K Buy
3,382
+1,357
+67% +$42.3K 0.01% 1402
2023
Q3
$62K Buy
+2,025
New +$97.7K 0.01% 1410

Other funds holding NUTX

GSA Capital Partners's NUTX Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Nutex Health (NUTX) in Q2 2026: 1,798 shares worth $307K. The stake represents 0.02% of the portfolio and ranks #1290 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in NUTX as recently as Q3 2025.

GSA Capital Partners first reported a position in NUTX in Q3 2023 and has held it in 5 quarters since. The position peaked at $489K in Q3 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • GSA Capital Partners held 1,798 shares of Nutex Health worth $307K as of Q2 2026.
  • Nutex Health was a new GSA Capital Partners position in Q2 2026.
  • Nutex Health made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1290 holding.
  • GSA Capital Partners first reported a position in Nutex Health in Q3 2023 and has held it in 5 quarters since.
  • GSA Capital Partners's Nutex Health position peaked at $489K in Q3 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.